AI assistant
CME GROUP INC. — Director's Dealing 2026
Mar 17, 2026
29871_dirs_2026-03-17_62b5fe35-ca38-42a9-9532-a5f694817980.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2026-03-15
Reporting Person: McCourt Timothy Francis (Sr MD Global Head Equity & FX)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-03-15 | Common Stock Class A | A | 5504 | $311.40 | Acquired | 15012 | Direct |
| 2026-03-15 | Common Stock Class A | F | 2810 | $311.40 | Disposed | 12202 | Direct |
| 2026-03-15 | Common Stock Class A | F | 94 | $311.40 | Disposed | 12108 | Direct |
Footnotes
F1: Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025.
F2: Mr. McCourt surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award.
F3: Mr. McCourt surrendered shares to the company to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2026.